All In MedTech

Device Trial Radar · NCT06872905

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

158

Planned (sponsor's estimate)

Start

May 30, 2025

Primary completion

Aug 16, 2027

Study completion Aug 16, 2027

Sponsor

Lead sponsor
W.L.Gore & AssociatesNot on our public-company list
Sponsor type
Industry
First posted
Mar 12, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will assess the safety and effectiveness of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis ("VBX Device" or also referred to as "VBX Stent Graft") in a post approval setting and evaluate the quality of the use in covered endovascular reconstruction of the aortic bifurcation (CERAB) to treat Aortoiliac Occlusive Disease (AIOD).

Conditions

  • Aortoiliac Occlusive Disease

Interventions

  • GORE VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX)Device

    Treatment of Target Lesions with the VBX Device in the aortic and common iliac positions during the CERAB procedure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Effectiveness Endpoint: 1-Year Primary patency (hypothesis testing)Time frame: 1-Year

1 more outcomes with a free account

Locations

27 sites in 5 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

26 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.